Koblan; Kenneth S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koblan; Kenneth S..The latest application filed is for "dosage of dasotraline and method for treatment of adhd".

Company Profile

0.4.6

Koblan; Kenneth S. - Brookline MA
Koblan; Kenneth S. - Carversville PA
Koblan; Kenneth S. - Chalfont PA
Koblan, Kenneth S - Rahway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosage of dasotraline and method for treatment of ADHD Grant 10,076,503 - Loebel , et al. September 18, 2	2018-09-18
Methods And Compositions Of Dasotraline For Treatment Of Adhd App 20170266133 - LOEBEL; Antony D. ; et al.	2017-09-21
Dosage Of Dasotraline And Method For Treatment Of Adhd App 20170266134 - LOEBEL; Antony D. ; et al.	2017-09-21
Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods Grant 7,193,070 - Kane , et al. March 20, 2	2007-03-20
Enhancement of sleep with t-type calcium channel antagonists App 20060003985 - Renger; John J. ; et al.	2006-01-05
Radioligand and binding assay Grant 6,838,291 - Butcher , et al. January 4, 2	2005-01-04
Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods App 20040197859 - Kane, Stefanie A. ; et al.	2004-10-07
Human tuberoinfundibular peptide of 39 residues App 20040106773 - Wang, Hao ; et al.	2004-06-03
Radioligand and binding assay App 20020034730 - Butcher, John W. ; et al.	2002-03-21
Inhibitors of phosphoinositide-specific phospholipase C Grant 5,519,163 - Gibbs , et al. May 21, 1	1996-05-21

Company Registrations

SEC

0001506914

KOBLAN KENNETH S

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.